Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis

The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates originating from patients with onychomycosis. Tavaborole had low activity against all isolates compared to itraconazole, terbinafine, and fluconaz...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Abastabar, Mahdi, Haghani, Iman, Shokohi, Tahereh, Hedayati, Mohammad Taghi, Aghili, Seyed Reza, Jedi, Ali, Dadashi, Sulmaz, Shabanzadeh, Shafigheh, Hosseini, Tahereh, Aslani, Narges, Meis, Jacques F., Badali, Hamid
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2018
Assuntos:
Susceptibility
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256807/
https://ncbi.nlm.nih.gov/pubmed/30224524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01632-18
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares